Back
Edgewise Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison
Buy
72
EWTX
Edgewise Therapeutics
Last Price:
30.11
Seasonality Move:
13.73%
Sell
48
VRTX
Vertex Pharmaceuticals
Last Price:
470.20
Seasonality Move:
7.68%
Buy
72
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $30.33. The Score for EWTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $467.97. The Score for VRTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $30.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $467.97
The current trend is relatively stagnant and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.47 | Buy |
| Relative Strength Index (14 RSI): | 71.49 | Buy |
| Chaikin Money Flow: | 1376532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.65 - 28.39) | Buy |
| Bollinger Bands (100): | (16.13 - 23.39) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.01 | Sell |
| Relative Strength Index (14 RSI): | 50.42 | Buy |
| Chaikin Money Flow: | 953823 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (458.3 - 477.48) | Buy |
| Bollinger Bands (100): | (460.39 - 489.13) | Sell |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.85 | Buy |
| 20-day SMA: | 25.06 | Buy |
| 50-day SMA: | 20.75 | Buy |
| 200-day SMA: | 17.95 | Buy |
| 8-day EMA: | 27.95 | Buy |
| 20-day EMA: | 25.53 | Buy |
| 50-day EMA: | 22.44 | Buy |
| 200-day EMA: | 17.77 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 460.2 | Buy |
| 20-day SMA: | 467.21 | Buy |
| 50-day SMA: | 474.31 | Sell |
| 200-day SMA: | 445.65 | Buy |
| 8-day EMA: | 460.72 | Buy |
| 20-day EMA: | 465.21 | Buy |
| 50-day EMA: | 470.52 | Sell |
| 200-day EMA: | 443.45 | Buy |
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.
Edgewise Therapeutics Technical Analysis
| Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||